129 related articles for article (PubMed ID: 33983375)
1. Costs Associated With Imaging Surveillance After Treatment for Head and Neck Cancer.
Nocon CC; Kennedy A; Jaffe J; Pruitt J; Kuchta K; Bhayani MK
JAMA Otolaryngol Head Neck Surg; 2021 Jul; 147(7):632-637. PubMed ID: 33983375
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy.
Ng SP; Pollard C; Berends J; Ayoub Z; Kamal M; Garden AS; Bahig H; Cantor SB; Schaefer AJ; Ajayi T; Gunn GB; Frank SJ; Skinner H; Phan J; Morrison WH; Ferrarotto R; Johnson JM; Mohamed ASR; Lai SY; Hessel AC; Sturgis EM; Weber RS; Fuller CD; Rosenthal DI
Cancer; 2019 Jun; 125(11):1823-1829. PubMed ID: 30748005
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Optimal Assessment Schedules for Surveillance After Definitive Locoregional Treatment of Locally Advanced Head and Neck Cancer: A Retrospective Cohort Study With Parametric Modeling of Event-Free Survival.
Lee HI; Lee J; Lee JH; Wu HG; Kim JH; Kim Y; Eom KY
JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1059-1067. PubMed ID: 36173618
[TBL] [Abstract][Full Text] [Related]
4. Patient Characteristics and Costs in Recurrent or Refractory Head and Neck Cancer: Retrospective Analysis of a Community Oncology Database.
Fisher MD; Fernandes AW; Olufade TO; Miller PJ; Walker MS; Fenton M
Clin Ther; 2018 Apr; 40(4):562-573. PubMed ID: 29530457
[TBL] [Abstract][Full Text] [Related]
5. Quantifying Total and Out-of-Pocket Costs Associated With Head and Neck Cancer Survivorship.
Massa ST; Chidambaram S; Luong P; Graboyes EM; Mazul AL
JAMA Otolaryngol Head Neck Surg; 2022 Dec; 148(12):1111-1119. PubMed ID: 36264567
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Social Vulnerability in Pediatric Head and Neck Cancer Care and Prognosis in the United States.
Fei-Zhang DJ; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
JAMA Netw Open; 2023 Feb; 6(2):e230016. PubMed ID: 36800183
[TBL] [Abstract][Full Text] [Related]
7. Postradiotherapy surveillance practice for head and neck squamous cell carcinoma--too much for too little?
Schwartz DL; Barker J; Chansky K; Yueh B; Raminfar L; Drago P; Cha C; Austin-Seymour M; Laramore GE; Hillel AD; Weymuller EA; Wallner KE
Head Neck; 2003 Dec; 25(12):990-9. PubMed ID: 14648857
[TBL] [Abstract][Full Text] [Related]
8. Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients.
Kim Le T; Winfree KB; Yang H; Marynchenko M; Yu AP; Frois C; Wu EQ
J Med Econ; 2012; 15(4):786-95. PubMed ID: 22475042
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up.
Imbimbo M; Alfieri S; Botta L; Bergamini C; Gloghini A; Calareso G; Orlandi E; Iacovelli NA; Guzzo M; Granata R; Resteghini C; Locati L; Volpi CC; Licitra L; Bossi P
Otolaryngol Head Neck Surg; 2019 Oct; 161(4):635-642. PubMed ID: 31286827
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of chemotherapy-treated recurrent and/or metastatic squamous cell carcinoma of the head and neck in France: real-world data from the permanent sample of national health insurance beneficiaries.
Lafuma A; Cotté FE; Le Tourneau C; Emery C; Gaudin AF; Torreton E; Gourmelen J; Bonastre J
J Med Econ; 2019 Jul; 22(7):698-705. PubMed ID: 30895832
[No Abstract] [Full Text] [Related]
11. Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques.
Leeman JE; Li JG; Pei X; Venigalla P; Zumsteg ZS; Katsoulakis E; Lupovitch E; McBride SM; Tsai CJ; Boyle JO; Roman BR; Morris LGT; Dunn LA; Sherman EJ; Lee NY; Riaz N
JAMA Oncol; 2017 Nov; 3(11):1487-1494. PubMed ID: 28542679
[TBL] [Abstract][Full Text] [Related]
12. Practice patterns of carotid endarterectomy as performed by different surgical specialties at a single institution and the effect on perioperative stroke and cost of preoperative imaging.
AbuRahma AF; Srivastava M; Hass SM; Chong B; AbuRahma Z; Dean LS; Stone PA; Mousa AY
J Vasc Surg; 2014 Nov; 60(5):1232-1237. PubMed ID: 24912971
[TBL] [Abstract][Full Text] [Related]
13. Temporal patterns of head and neck squamous cell carcinoma recurrence with positron-emission tomography/computed tomography monitoring.
Beswick DM; Gooding WE; Johnson JT; Branstetter BF
Laryngoscope; 2012 Jul; 122(7):1512-7. PubMed ID: 22685038
[TBL] [Abstract][Full Text] [Related]
14. Association of Head and Neck Cancer With Mental Health Disorders in a Large Insurance Claims Database.
Lee JH; Ba D; Liu G; Leslie D; Zacharia BE; Goyal N
JAMA Otolaryngol Head Neck Surg; 2019 Apr; 145(4):339-344. PubMed ID: 30816930
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the Financial Burden of Survivors of Head and Neck Cancer With Other Cancer Survivors.
Massa ST; Osazuwa-Peters N; Adjei Boakye E; Walker RJ; Ward GM
JAMA Otolaryngol Head Neck Surg; 2019 Mar; 145(3):239-249. PubMed ID: 30789634
[TBL] [Abstract][Full Text] [Related]
16. An Analysis of 1-Year Charges for Head and Neck Cancer: Targets for Value-Based Interventions.
Pang J; Crawford K; Faraji F; Ramsey C; Kemp A; Califano JA
Otolaryngol Head Neck Surg; 2020 Sep; 163(3):546-553. PubMed ID: 32450778
[TBL] [Abstract][Full Text] [Related]
17. Variation in head and neck cancer care in the Netherlands: A retrospective cohort evaluation of incidence, treatment and outcome.
de Ridder M; Balm AJM; Baatenburg de Jong RJ; Terhaard CHJ; Takes RP; Slingerland M; Dik E; Sedee RJE; de Visscher JGAM; Bouman H; Willems SM; Wouters MW; Smeele LE; van Dijk BAC;
Eur J Surg Oncol; 2017 Aug; 43(8):1494-1502. PubMed ID: 28336186
[TBL] [Abstract][Full Text] [Related]
18. The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluation.
Meregaglia M; Cairns J; Licitra L; Bossi P
Eur J Cancer; 2018 Apr; 93():89-98. PubMed ID: 29477796
[TBL] [Abstract][Full Text] [Related]
19. Value of FDG PET in assessment of treatment response and surveillance in head-and-neck cancer patients after intensity modulated radiation treatment: a preliminary report.
Yao M; Graham MM; Smith RB; Dornfeld KJ; Skwarchuk M; Hoffman HT; Funk GF; Graham SM; Menda Y; Buatti JM
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1410-8. PubMed ID: 15590172
[TBL] [Abstract][Full Text] [Related]
20. Comparing the costs of three prostate cancer follow-up strategies: a cost minimisation analysis.
Pearce AM; Ryan F; Drummond FJ; Thomas AA; Timmons A; Sharp L
Support Care Cancer; 2016 Feb; 24(2):879-886. PubMed ID: 26245495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
